Gunnar Sturfelt (Former)
61 – 70 of 182
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Effect of Medication on Microvascular Vasodilatation in Patients with Systemic Lupus Erythematosus
(
- Contribution to journal › Article
-
Mark
Atherosclerotic Vascular Events in a Multinational Inception Cohort of Systemic Lupus Erythematosus
(
- Contribution to journal › Article
-
Mark
The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE.
(
- Contribution to journal › Article
-
Mark
Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.
(
- Contribution to journal › Article
- 2009
-
Mark
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints
(
- Contribution to journal › Scientific review
-
Mark
C1q Inhibits Immune Complex-Induced Interferon-alpha Production in Plasmacytoid Dendritic Cells A Novel Link Between C1q Deficiency and Systemic Lupus Erythematosus Pathogenesis
(
- Contribution to journal › Article
-
Mark
The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI)
(
- Contribution to journal › Article
-
Mark
Limitations of Antinuclear Antibody Tests (HEp-2) Are Overcome with the Autoimmune Target Test (IT-1) in Systemic Lupus Erythematosus Reply
(
- Contribution to journal › Letter